Efungumab clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How each study uses efungumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Mycograb
- 1
Studies by the year they started
3 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Novartis Pharmaceuticals (2) · NeuTec Pharma (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses efungumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedPhase 2Novartis PharmaceuticalsNCT00847678Written as Efungumab (Mycograb)
- Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedPhase 2Novartis PharmaceuticalsNCT00324025Written as Mycograb
- Preliminary Study of Mycograb and Docetaxel in Advanced Breast CancerCompletedPhase 1/2NeuTec PharmaNCT00217815Written as Mycograb, Docetaxel
Codes
What other systems call efungumab · ClinicalTrials.gg INT004948
- MeSH (NLM) C512268efungumabConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) BM86P708HWEFUNGUMABConfirmed FDA, NLM, Wikidata
- Wikidata Q3720273efungumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87763EfungumabOne source FDA
- DrugBank DB16151One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C512268 | efungumab | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | BM86P708HW | EFUNGUMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3720273 | efungumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87763 | Efungumab | One source FDA |
| DrugBank | DB16151 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.